HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Experts Address Chondroitin Testing In Wake Of ConsumerLab Report

This article was originally published in The Tan Sheet

Executive Summary

Results of a recent ConsumerLab.com report on joint supplements that found 7 out of 11 tested products contained less chondroitin than stated on the label did not surprise experts in the industry

You may also be interested in...

Advanced Testing Would Spike Drug, Supplement Prices – Industry Experts

Costs for drug and nutraceutical ingredients could rise sharply if firms pursue the level of testing needed to screen for contaminants like the substance found recently in heparin

Industry Input Will Bolster Risk-Based Inspection Approach – FDA’s Ellsworth

FDA is "hoping" to use future facility inspections to compile data that will strengthen the "process risk" prong of its risk-based site selection model by gaining knowledge about quality systems currently in use by industry, according to New Jersey District Director Douglas Ellsworth

Blame China? Experts Advise Congress, Industry Take A Wider View

The global scope of food safety is becoming apparent, and recent problems with products imported from China are but a part of U.S. food safety concerns, industry experts say





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts